France vs Singapore: Cause of death, by non-communicable diseases, ages 5-14
France
64.5%
in 2021
Singapore
65.3%
in 2021
France rank
20th
Singapore rank
18th
Cause of death, by non-communicable diseases, ages 5-14 over time
- France
- Singapore
How they compare
Singapore currently reports 65.3% against 64.5% in France, a difference of 0.8%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Singapore ahead.
France ranks 20th and Singapore ranks 18th of 185 countries.
Across the 3 decades both report, France averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | France | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.7% | 59.8% | 8.2% | Singapore |
| 2010s | 65.8% | 63.2% | 2.6% | France |
| 2020s | 63.4% | 58.8% | 4.6% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, France or Singapore?
- Singapore, at 65.3% against 64.5% in France as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between France and Singapore?
- 0.8%, with Singapore ahead.
- How many years of comparable data are there for France and Singapore?
- 6 years are reported by both, from 2000 to 2021.
- How do France and Singapore rank globally for cause of death, by non-communicable diseases, ages 5-14?
- France ranks 20th and Singapore ranks 18th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.